EMINENCE ENT (Hong Kong) Today

Equity ratings for EMINENCE ENT are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2020 and ending today, the 26th of November 2022. Click here to learn more.
EMINENCE ENT cannot be verified against its exchange. It appears EMINENCE ENT is not available for investing at the moment. Please verify the symbol is currently traded on Hong Kong Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

EMINENCE ENT Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. EMINENCE ENT's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding EMINENCE ENT or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
EMINENCE ENT is not yet fully synchronised with the market data
EMINENCE ENT has some characteristics of a very speculative penny stock
EMINENCE ENT has high likelihood to experience some financial distress in the next 2 years
EMINENCE ENT has accumulated about 253.94 M in cash with (109.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
ChairmanCheung Kwong
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of EMINENCE ENT's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
EMINENCE ENT (0616) is traded on Hong Kong Stock Exchange in Hong Kong and employs 55 people. The company currently falls under 'Small-Cap' category with current market capitalization of 111.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EMINENCE ENT's market, we take the total number of its shares issued and multiply it by EMINENCE ENT's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. EMINENCE ENT operates under Real Estate sector and is part of Real Estate Services industry. The entity has 3.73 B outstanding shares. EMINENCE ENT has accumulated about 253.94 M in cash with (109.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check EMINENCE ENT Probability Of Bankruptcy

EMINENCE Stock Against Markets

Picking the right benchmark for EMINENCE ENT stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in EMINENCE ENT stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for EMINENCE ENT is critical whether you are bullish or bearish towards EMINENCE ENT at a given time.
EMINENCE ENT cannot be verified against its exchange. It appears EMINENCE ENT is not available for investing at the moment. Please verify the symbol is currently traded on Hong Kong Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

EMINENCE ENT Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EMINENCE ENT stock to make a market-neutral strategy. Peer analysis of EMINENCE ENT could also be used in its relative valuation, which is a method of valuing EMINENCE ENT by comparing valuation metrics with similar companies.
HUA HONG SEMIAmn Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpGx Nasdaq-100 CoveredFranklin Mutual EuropeanBhp BillitonNatural Hlth TrdUSA Value FactorBetapro Canadian GoldAramark Holdings CorpLong-Term Govt BondSeagate Technology HldgsVistra Energy CorpExxon Mobil Corp
 Risk & Return  Correlation

EMINENCE ENT Corporate Directors

EMINENCE ENT corporate directors refer to members of an EMINENCE ENT board of directors. The board of directors generally takes responsibility for the EMINENCE ENT's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of EMINENCE ENT's board members must vote for the resolution. The EMINENCE ENT board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Tak Foo - Independent Non-Executive DirectorProfile
Koon Wu - Non-Executive Independent DirectorProfile
Lai Kau - Non-Executive DirectorProfile
Wing Tse - Non-Executive DirectorProfile

Invested in EMINENCE ENT?

The danger of trading EMINENCE ENT is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of EMINENCE ENT is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than EMINENCE ENT. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile EMINENCE ENT is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Tools for EMINENCE Stock

When running EMINENCE ENT price analysis, check to measure EMINENCE ENT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMINENCE ENT is operating at the current time. Most of EMINENCE ENT's value examination focuses on studying past and present price action to predict the probability of EMINENCE ENT's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move EMINENCE ENT's price. Additionally, you may evaluate how the addition of EMINENCE ENT to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go